iwCLL guidelines for diagnosis, indications for treatment, …
2018年6月21日 · Updates regarding the baseline assessment and prophylaxis of viral diseases before and under therapy of CLL.
ALL, AML, CLL, CML......搞混了！！！一文简单解读白血病分类 - 儒 …
2019年8月28日 · 和髓系白血病的原理一样，淋巴系白血病也可以分为急性淋巴系白细胞（ALL）和慢性淋巴系白血病 (CLL)，由于淋巴系主要为B细胞和T细胞，因而又可以笼统的分 …
Chronic Lymphocytic Leukemia: 2025 Update on the Epidemiology …
2025年1月28日 · Disease overview: Chronic lymphocytic leukemia (CLL) is the most frequent type of leukemia. It typically occurs in older patients and has a highly variable clinical course. …
Fixed-Duration Acalabrutinib Plus Venetoclax with or without ...
2024年11月5日 · Background: In patients with treatment-naive (TN) chronic lymphocytic leukemia (CLL), both continuous Bruton tyrosine kinase inhibitor (BTKi) monotherapy and fixed-duration …
Precision diagnostics in chronic lymphocytic leukemia: Past, …
2023年3月21日 · We discuss different state-of-the-art technologies that are applied to enable precision diagnostics in CLL and highlight important genomic markers with current prognostic …
Acute Lymphoblastic Leukemia vs. Chronic Lymphocytic Leukemia
2024年7月2日 · Acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) are two types of blood cancer that affect specific white blood cells produced by the bone marrow, …
Transformation of chronic lymphocytic leukemia into B-cell …
2018年3月15日 · Here we report an unexpected clinical outcome: acute lymphoblastic leukemia (ALL) transformation in a CLL patient while he was receiving a PI3Ki, which requires attention …
Cubing Trainer
Memorize algorithms at lightning speed. You can learn OLL, PLL, CLL, and more.
Chronic lymphocytic leukemia: 2022 update on diagnostic and
2021年12月1日 · Disease overview: Chronic lymphocytic leukemia (CLL) is one of the most frequent types of leukemia. It typically occurs in elderly patients and has a highly variable …
Atrial fibrillation in patients with chronic lymphocytic leukemia …
Ibrutinib therapy is associated with an increased risk of atrial fibrillation (AF) in chronic lymphocytic leukemia (CLL). Risk assessment tools and outcomes of AF in these patients are …